[{"id":"7cc580e8-c1f3-4929-85f2-d9ad42d412c9","acronym":"","url":"https://clinicaltrials.gov/study/NCT02968810","created_at":"2021-01-18T14:35:38.364Z","updated_at":"2024-07-02T16:35:09.555Z","phase":"Phase 2","brief_title":"Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis","source_id_and_acronym":"NCT02968810","lead_sponsor":"National Cancer Institute (NCI)","biomarkers":" AFP","pipe":" | ","alterations":" ALPL-H","tags":["AFP"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e ALPL-H"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e simvastatin"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 59","initiation":"Initiation: 06/21/2017","start_date":" 06/21/2017","primary_txt":" Primary completion: 05/03/2023","primary_completion_date":" 05/03/2023","study_txt":" Completion: 12/31/2024","study_completion_date":" 12/31/2024","last_update_posted":"2024-04-16"},{"id":"1e85ee52-7d64-4842-bb2c-5ba2eab90c67","acronym":"B1871040","url":"https://clinicaltrials.gov/study/NCT01903733","created_at":"2021-08-17T20:53:11.296Z","updated_at":"2024-07-02T16:36:07.142Z","phase":"","brief_title":"Bosutinib Treatment Extension Study Only For Subjects With Chronic Myeloid Leukemia (CML) Who Have Previously Participated In Bosutinib Studies B1871006 Or B1871008","source_id_and_acronym":"NCT01903733 - B1871040","lead_sponsor":"Pfizer","biomarkers":" ABL1 • BCR","pipe":" | ","alterations":" ALPL-H","tags":["ABL1 • BCR"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e ALPL-H"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e bosutinib"],"overall_status":"Completed","enrollment":" Enrollment 281","initiation":"Initiation: 08/28/2013","start_date":" 08/28/2013","primary_txt":" Primary completion: 06/05/2020","primary_completion_date":" 06/05/2020","study_txt":" Completion: 06/05/2020","study_completion_date":" 06/05/2020","last_update_posted":"2022-07-19"}]